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ABSTRACT 
 
Background: The role of inflammation and neutrophil/lymphocyte ratio has been defined in systolic heart failure 
(HF) and coronary artery disease, but it is uncertain if such a relationship exists in HF with preserved ejection 
fraction (HFpEF) patients (pts). We sought to identify the prognostic impact of Absolute Neutrophil Count (ANC) in 
HFpEF in the absence of coronary artery disease history (CAD Hx).Methods: In this retrospective cohort, the 
institutional HF data base was queried to identify HFpEF pts diagnosed in 2006 (registry initiation date) based on 
symptoms, BNP, and Echocardiogram with no CAD Hx. Measured outcomes were cardiovascular disease (CVD) 
mortality and number of HF re-admissions (poor outcome if > 2 HF re-admissions). Results: We identified 125 
eligible pts. Mean age was 70.8 ± 11.7 years. Women constituted 56.6%. Mean follow up was for 8.75 ± 0.17 years. 
The CVD mortality rate was 7.1%. Poor outcome was identified in 52.6%. Mean ANC was 6.3 ± 3.2, and in 
multivariate regression analysis, including baseline demographic, clinical, and biochemical covariates, ANC 
remained significantly associated with poor outcome and an independent predictor of mortality (OR 1.14, 95% CI 
1.02-1.29, P=0.04 after adjustment for age, sex, hypertension, and other risk factors)(table). 
Conclusion: In HFpEF pts, ANC is a significant predictor of poor outcome as well as mortality in the absence of 
coronary artery disease. Accordingly, ANC can be utilized as one of the non-invasive prognostic markers in HFpEF 
patients.   
Keywords: Absolute Neutrophil Count; Heart Failure with Preserved Ejection Fraction; Cardiovascular disease 
mortality.  
Introduction 
 
The relationship of markers of inflammation including 
white blood cells (WBCs) and their subtypes, and 
cardiovascular disease has been examined in many 
studies, especially the association with coronary artery 
disease (CAD). It was shown that total WBCs, 
neutrophil count and lymphocyte count were 
independent risk factors of mortality and MI in patients 
with CAD, and worsening of their CAD [1-3]. Less so, 
it has also been studied in patients with heart failure 
(HF); markers of inflammation, like Interleukin (IL)-6 
and tumor necrosis alpha (TNF)-alpha have also been 
found to be associated with increased incidence of 
heart failure [4-8], Erythrocyte sedimentation rate  
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(ESR) and C-reactive protein (CRP) were also 
described as predictors of developing HF [9,10]. This 
could be explained as a causal relationship where these 
inflammatory mediators actually play a role in the 
development of heart failure or merely their presence 
being a marker of the underlying process causing left 
ventricular modelling and HF. All the available data 
were from patient with systolic heart failure but no 
study to date evaluated the significance of such as 
association in heart failure with preserved ejection 
fraction (HFpEF). Given the scarce evidence in the 
literature we aimed to evaluate the prognostic impact 
of absolute neutrophil count in patients with HFpEF.   
 
Patients and methods 
 
This study was conducted following the approval of 
our Institutional Review Board. In this retrospective 
cohort, our institutional heart failure database was 
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reviewed. All patients HFpEF diagnosis on 2006 were 
included.  All patients with confirmed HFpEF 
diagnosis based on symptoms, brain natriuretic peptide 
(BNP), and transthoracic echocardiogram were 
included.  Ejection fraction of 50% or more was 
considered as cut off for the diagnosis.   
Primary outcome was identified cardiovascular disease 
mortality. Secondary outcome included number of 
heart failure re-admissions with poor outcome defined 
as more than two re-admissions during the follow up 
period of 9 years.  
 
Statistical Analysis 
 
All data including patient’s demographics, medical 
history, medications, clinical presentation, ECG, and 
echocardiographic details were obtained from advocate 
Illinois masonic clinical records and our prospectively 
collected databases. In addition, the source for follow-
up information was subsequent clinic visits, hospital 
admissions, emergency room visits, and written 
correspondence from local physicians. Descriptive 
statistics for data with normal distribution were 
presented as means and standard deviations from the 
mean, while any other type of data distribution was 
presented using median with range. Counts and 
percentages were used for dichotomous and categorical 
data. Comparison between two groups was tested for 
continuous and dichotomous variables using Student’s 
paired t test and χ2, respectively.  Cox regression 
modelling and multivariate analysis were used to assess 
the independent contribution of all relevant clinical 
variables to the outcome. Probability value (p-value) of 
≤ 0.05 was identified as a cut-off for statistical 
significance. 
 
Results 
 
Table 1: Baseline characteristics of patients with HFpEF (EF cutoff of >50%) 
 
Descriptive Statistics 
 N Minimu
m 
Maximu
m 
Mean Std. 
Deviation 
Age 249 27 98 72.15 13.400 
BMI (kg/m2) 249 14.5 93.4 32.168 10.8590 
Height (cm) 249 2.0 191.0 164.358 15.1083 
Weight (kg) 249 42.3 852.0 91.335 57.4622 
BSA (m2) 249 1.40 197.00 3.9776 17.24746 
Hb (g/dl) 249 1.5 16.4 10.972 2.0200 
Hct 249 20.0 54.5 33.730 5.9931 
Platelets 249 31.0 600.0 226.789 79.3638 
WBC 249 3.3 20.1 8.730 3.0440 
ANC 249 1.22 25.50 6.3059 3.23054 
BNP 223 1.1 5000.0 587.270 726.9906 
Creatinine 
(mg/dl) 
249 .00 24.90 1.8155 1.82047 
PA pressure 
(mmHg) 
189 0 89 36.16 17.759 
LA size (cm) 236 1.0 5.9 3.877 .8402 
      
ANC: Absolute Neutrophil Count; BNP: Brain Natriuretic Peptide; BMI: Body Mass 
Index; BSA: Body Surface Area; Hb: Hemoglobin; Hct: Hematocrit; LA: Left atrium; 
PA : Pulmonary artery  
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Table 2: Multivariate regression analysis 
 
Variable OR 95.0% CI p-value 
Age (years) 1.0 0.97-1.02 0.73 
Sex 1.11 0.77-1.60 0.59 
BMI (kg/m2) 0.99 0.97-1.01 0.55 
ANC 1.14 1.02-1.29 0.04 
Hemoglobin(g/dl) 0.88 0.73-1.06 0.18 
 
ANC: Absolute Neutrophil Count; BMI: Body Mass Index; 
 
Of the total of 249 patients studied, 125 eligible 
patients were included based on the inclusion criteria. 
The baseline characteristics of these patients are listed 
in Table 1: Baseline characteristics of patients with 
HFpEF (EF cutoff of >50%)Mean age was 72 ± 13, 
Women constituted 56.6%. Mean follow up was for 
8.75 ± 0.17 years. BNP averaged 587 ± 727 and poor 
outcomes were identified in 52.6%. Mean ANC was 
6.3 ± 3.2.In a multivariate analysis model to adjust for 
important baseline characteristics, including age, 
gender, cardiovascular risk factors, CAD, atrial 
fibrillation and optimum management, we found that 
among the parameters described in Table 2, we found 
that ANC had statistically significant association with 
poor outcome (OR 1.14, 95% CI 1.02-1.29, P=0.04) 
 
Discussion 
 
Absolute neutrophilia has been shown to increase risk 
of developing HF after ischemic insult in a cohort 
study by Ypil et al [11], and in another cross-sectional 
study, absolute neutrophilia in the first 12 hours post-
acute myocardial infarction (MI) is a predictor of 
increased risk of post-MI HF [12].  Although the 
underlying mechanism is yet to be known, but it has 
been proposed that increased neutrophil count and 
activity causes infarct expansion [13,14], possibly due 
to an increase in oxidative stress [13,15] , tissue 
destruction with proteolytic enzymes like 
myeloperoxidase, acid phosphatase, and elastase [16-
19] or can contributed for by plugging capillary flow 
during reperfusion [20]. Whether neutrophilia also 
contributes to non-ischemic HF, and the mechanism of 
which is still unclear, it has been proposed it is induced 
by oxidative stress as well. It has been shown that 
oxidative stress can cause contractile dysfunction [21].   
In a study of the incidence of hospitalization of HF 
patients has shown and independently from coronary 
events, and after adjustment for angina, that 
concentration of leukocytes is associated with 
increased risk of HF hospitalization in men with and 
without hypertension [22]. Yet hypertension has also 
been linked to increased inflammatory markers, and its 
role in the development of heart failure is well-known, 
similarly, subclinical coronary events can contribute to 
HF exacerbations and hospitalizations and coronary 
disease has been linked to increased leukocytes as 
described above.  A retrospective analysis of the 
studies of left ventricular dysfunction also linked 
baseline increased WBC to all-cause mortality of 
patients with ischemic LV dysfunction but not with 
non-ischemic LV dysfunction [23]. Different white cell 
types have different mechanisms in inducing injury and 
inflammation, and conversely, lower lymphocyte 
counts have repeatedly been associated with increased 
risk of HF mortality and admissions [24-28]. 
Therefore, in an attempt to better elaborate the 
relationship, 2 studies have been conducted recently 
combining neutrophilic and lymphopenic effects by 
Neutrophil to Lymphocyte ratio (NLR) in relation to 
acute heart failure prognosis and mortality [29,30]. 
NLR was also associated with increased severity of 
chronic heart failure NYHA classification in patients 
with idiopathic cardiomyopathy [30].When HF patients 
were divided into groups with preserved EF and 
reduced EF, significant increased mortality was 
demonstrated in both groups [30]. NLR was also an 
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independent prognostic risk factor from ejection 
fraction in the second study by Vicente et al. 
[29].Despite the all the above evidence, it’s still 
unclear if neutrophils have any direct rule in the failure 
of relaxation of the heart muscle (diastolic dysfunction) 
in the absence of ischemic insult or infarcted 
myocardial tissue.  
 
Conclusion 
 
ANC remains to be a significant predictor of morbidity 
and mortality in patients with HFpEF after correcting 
for all risk factors, despite the absence of coronary 
artery disease. This indicates that underlying 
inflammation might be contributing to the diastolic 
dysfunction in the presence of normal perfusion. 
Accordingly, ANC might be a very useful non-invasive 
marker that can be utilized in risk stratifying patients 
with HFpEF.  
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